Foradil News
Most Popular Foradil Story
FDA panel votes down two asthma meds
When it came to the vote, the FDA's asthma drugs advisory panel wasn't as evenly split as it seemed. The experts voted unanimously to ban GlaxoSmithKline's Serevent and Schering-Plough/Novartis'... Read more...
Latest Headlines
- December 12, 2008
- December 11, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
